Top_Holders_Report (2) Categories: News & Announcements 2019, Top 20 ShareholdersBy PharmAustMay 6, 2019Related posts25 kg of GMP Monepantel from ElancoMay 8, 2019PharmAust Limited Monepantel Tablets Demonstrate High Safety During Phase I TrialMay 3, 2019Appendix 4C and Quarterly UpdateMay 1, 201930 April, Top 20 ShareholdersApril 30, 20192017 to 2018 R&D Tax Rebate: $672kApril 30, 2019Appendix 3BApril 24, 2019
